Natera Inc Stock
Price
Target price
€268.00
€268.00
0.070%
0.2
0.070%
-
14.08.26 / Tradegate
WKN: A14VPJ / Name: Natera / Stock / Healthcare Equipment & Supplies / Small Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Natera Inc Stock
There is nearly no change for the Natera Inc stock today. Compared to yesterday it only changed by €0.20.
Pros and Cons of Natera Inc in the next few years
Pros
?
M***** P*******
?
G***** c******* t* c**********
?
C******** o* t** e**********
Cons
?
W********* I********* f** t** n*** y****
?
S********** s********
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Natera Inc vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Natera Inc | 0.070% | -3.943% | 12.228% | 95.620% | 36.041% | 410.476% | 213.450% |
| Orthofix Medical Inc. | -2.290% | -1.724% | -15.347% | -27.542% | -33.721% | -52.235% | -74.091% |
| Lantheus Holdings Inc | -0.340% | -0.114% | -2.676% | 86.738% | 52.622% | 38.571% | - |
| IRadimed Corp | 0.000% | -5.031% | -12.209% | 24.793% | -9.036% | - | - |
News
What to Know About This Natera Insider Transaction as Shares Surge to Record Highs
Solomon Moshkevich, president of clinical diagnostics at Natera, Inc. (NASDAQ:NTRA), sold 3,410 shares of common stock on August 3, according to an SEC Form 4 filing.
Transaction value based on SEC
A Natera Co-Founder Sold 2,000 Shares From a Spouse's Account. Here's What It Suggests
Executive Chairman Matthew Rabinowitz reported a sale of 2,000 shares of Natera, Inc. (NASDAQ:NTRA) in a recent SEC Form 4 filing.
Transaction value based on SEC Form 4 weighted average sale price
Should You Worry That a Natera Co-Founder Sold Shares? Here's What Long-Term Investors Should Know
Matthew Rabinowitz, the executive chairman of Natera, Inc. (NASDAQ:NTRA), sold 731 shares of common stock at $267.99 per share on August 3, according to an SEC Form 4 filing.
Transaction value based